Skip to main content
Sign In

We are a nationally recognized department of Ophthalmology.

Othamology Banner Image

Faculty Publications

Jeffrey L Bennett, MD, PhD

The following data are linked to original publications.


    1. Kalluri, S.R., Illes, Z., Srivastava, R., Cree, B., Menge, T., Bennett, J.L., Berthele, A., Hemmer: Quantification and functional characterization of antibodies to native aquaporin-4 in neuromyelitis optica. Arch. Neurol., 2010 Oct;67(10):1201-8. PMCID: 20937947
    2. Warnke C, Menge T, Hartung HP, Racke MK, Cravens PD, Bennett JL, et al. Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided? Arch Neurol. 2010;67(8):923-30.
    3. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology. 2010;74(14):1127-35. PMCID: 2865779.
    4. Teunissen CE, Tumani HT, Bennett JL, Berven FS, Brundin L, Comabella M, et al. Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'. Mult Scler. 2010;16(2):129-32.
    5. Awad A, Hemmer B, Hartung HP, Kieseier B, Bennett JL, Stuve O. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. J Neuroimmunol. 2010;219(1-2):1-7.
    6. Crane JM, Bennett JL, Verkman AS. Live cell analysis of aquaporin-4 m1/m23 interactions and regulated orthogonal array assembly in glial cells. J Biol Chem. 2009;284(51):35850-60. PMCID: 2791014.
    7. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology. 2009;73(22):1914-22. PMCID: 2839806.
    8. Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol. 2009;66(5):617-29.
    9. Cameron EM, Spencer S, Lazarini J, Harp CT, Ward ES, Burgoon M, et al. Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. J Neuroimmunol. 2009;213(1-2):123-30. PMCID: 2785005.
    10. Owens GP, Bennett JL, Lassmann H, O'Connor KC, Ritchie AM, Shearer A, et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol. 2009;65(6):639-49. PMCID: 2843543.
    11. Bennett JL, Stuve O. Update on inflammation, neurodegeneration, and immunoregulation in multiple sclerosis: therapeutic implications. Clin Neuropharmacol. 2009;32(3):121-32.
    12. Burgoon MP, Cohrs RJ, Bennett JL, Anderson SW, Ritchie AM, Cepok S, et al. Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis. Ann Neurol. 2009;65(4):474-9. PMCID: 2844106.
    13. Athappilly G, Pelak VS, Mandava N, Bennett JL. Ischemic optic neuropathy.  Neurol Res. 2008;30(8):794-800.
    14. Bennett JL, Haubold K, Ritchie AM, Edwards SJ, Burgoon M, Shearer AJ, et al. CSF IgG heavy-chain bias in patients at the time of a clinically isolated syndrome. J Neuroimmunol. 2008;199(1-2):126-32. PMCID: 2572301.
    15. Stuve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, et al. Pharmacological treatment of early multiple sclerosis. Drugs. 2008;68(1):73-83.
    16. Winges KM, Gilden DH, Bennett JL, Yu X, Ritchie AM, Owens GP. Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts. J Neuroimmunol. 2007;192(1-2):226-34.
    17. Owens GP, Winges KM, Ritchie AM, Edwards S, Burgoon MP, Lehnhoff L, et al. VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis. J Immunol. 2007;179(9):6343-51.
    18. Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol. 2007;27(3):238-40.
    19. Kaur P, Bennett JL. Optic neuritis and the neuro-ophthalmology of multiple sclerosis. Int Rev Neurobiol. 2007;79:633-63.
    20. Galetta, S.L., Bennett J.L.: Neuromyelitis optica is a variant of multiple sclerosis.  Arch. Neurology. 2007; 64:901-903.
    21. Owens GP, Ritchie AM, Gilden DH, Burgoon MP, Becker D, Bennett JL. Measles virus-specific plasma cells are prominent in subacute sclerosing panencephalitis CSF. Neurology. 2007;68(21):1815-9.
    22. Stuve O, Bennett JL. Pharmacological properties, toxicology and scientific rationale for the use of natalizumab (Tysabri) in inflammatory diseases. CNS Drug Rev. 2007;13(1):79-95.
    23. Olson JL, Bennett J, Mandava N. Cerebellar and retinal vascular lesions in a postpartum patient. Am Fam Physician. 2007;75(3):393-4.
    24. Owens GP, Shearer AJ, Yu X, Ritchie AM, Keays KM, Bennett JL, et al. Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein. J Virol. 2006;80(24):12121-30. PMCID: 1676253.
    25. Simon, J.H., Zhang, S., Laidlaw, D.H., Miller, D.E., Brown, M., Corboy, J., Bennett J.L. Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome.  J. Magn. Reson. Imaging. 2006; 24:983-988.
    26. Owens GP, Bennett JL, Gilden DH, Burgoon MP. The B cell response in multiple sclerosis. Neurol Res. 2006;28(3):236-44.
    27. Bennett JL. Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis. Neurol Res. 2006;28(3):291-8.